66(1)Section 129 (regulations as to pharmaceutical services) is amended as follows.E+W
(2)In subsection (1), for “a Primary Care Trust” substitute “the Board”.
(3)In subsection (2)—
(a)in paragraph (a)—
(i)for “a Primary Care Trust” substitute “the Board”, and
(ii)for “the area of the Primary Care Trust” substitute “England”,
(b)in paragraph (b), for “a Primary Care Trust” substitute “the Board”, and
(c)in paragraph (c), for “the Primary Care Trust” substitute “the Board”.
(4)After subsection (2ZA) (inserted by section 207(3)) insert—
“(2ZB)Regulations under subsection (2)(a) may, in particular, require a list of persons to be prepared by reference to the area in which the premises from which the services are provided are situated (and regulations imposing that requirement must prescribe the description of area by reference to which the list is to be prepared).”
(5)In subsection (2A), for “The Primary Care Trust” substitute “The Board”,
(6)In subsections (2C), (3A), (4), (5) and (8), for “the Primary Care Trust”, in each place it appears, substitute “the Board”.
(7)In subsection (6)—
(a)in paragraphs (za), (a), (b), (c), (d), (g), (h), (i), (j) and (k), for “a Primary Care Trust” substitute “the Board”,
(b)in paragraphs (b), (e) and (k), for “the Primary Care Trust”, in each place it appears, substitute “the Board”, and
(c)in paragraph (f), for “that Primary Care Trust” substitute “the Board”.
(8)In subsection (6)(c)—
(a)for “the Primary Care Trust”, in the first place it appears, substitute “the Board”, and
(b)omit “in the area of the Primary Care Trust”.
(9)In subsection (10A), for “Primary Care Trusts” substitute “The Board”.
Commencement Information
I1Sch. 4 para. 66 in force at 1.4.2013 in so far as not already in force by S.I. 2013/160, art. 2(2) (with arts. 7-9)
I2Sch. 4 para. 66 partly in force; Sch. 4 para. 66 in force for specified purposes at Royal Assent, see s. 306(1)(d)